Biotechnology

FDA panel backs full approval for Eisai, Biogen Alzheimer’s drug

The Food and Drug Administration is more likely to grant a broader approval to a closely watched therapy for Alzheimer’s disease, now that it’s...

Top News

Groundbreaking CRISPR Therapy Set to Revolutionize Healthcare: FDA Nears Approval Decision

--Must See-- Groundbreaking CRISPR Therapy Set to Revolutionize Healthcare: FDA Nears Approval Decision The field of gene editing has witnessed remarkable advancements over the past decade,...

Chronic myeloid leukemia: Novartis survey signals need for better patient-physician communication 

Only 19% to 26% of patients with chronic myeloid leukemia (CML) discuss treatment decisions with their physician, a survey by Swiss-based pharmaceutical Novartis has...

Extremist Beliefs Among Veterans, Space Traffic, Teacher Well-Being: RAND Weekly Recap

This week, we discuss evidence suggesting that veterans don’t support extremism any more than the public does; why it’s time to manage traffic...

Indian hospitals set their sights on green healthcare infrastructure to improve patient recovery

Indian hospitals set their sights on green healthcare infrastructure to improve patient recovery Posted on June 9, 2023 Updated on June 6, 2023...

ddRAD sequencing based genotyping of six indigenous dairy cattle breeds of India to infer existing genetic diversity and population structure – Scientific Reports

Quality control, alignment and SNP callingThe ddRAD sequencing based genotyping of 58 individuals belonging to six native cattle breeds; Gir, Sahiwal, Tharparkar, Rathi, Red...

Introducing PALADIN

The past decade has seen a proliferation in the number of investigational therapies and the number of companies sponsoring active clinical trials. At the...

If AI invents a new medicine, who gets the patent?

Pharmaceutical and biotech companies are increasingly using artificial intelligence to discover and make drugs and therapeutics. Congress on Wednesday asked the question: Does that...

A novel way to diagnose early-onset atopic dermatitis using sebum

Eczema is an inflammatory skin condition that often affects infants as young as one to two months. Among the various types of eczema seen...

Armed with new gene therapy tools, a biotech startup promises a better way to target muscle diseases

For something as pinpoint as a gene, gene therapy can be a blunt tool for treating diseases that affect parts of the body, like...

Acepodia raises $100M financing to boost cell therapies

Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its antibody-cell conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms to address...

CGT Catapult expanding with Scotch facility

The world 3rd largest gene and cell therapy (CGT) cluster, the UK CGT Catapult has expanded its operations opening a subsidiary in Edinburgh....

Leqembi – FDA’s chance for an Alzheimer’s do-over

ARTICLE | RegulationThree reasons why FDA’s meeting to discuss lecanemab will be less contentious than its aducanumab meeting By Selina Koch, Executive Editor June 8,...

Latest Intelligence

spot_img
spot_img